Alternative for surgical management of calcific aortic valve stenosis: sutureless valve implants.
Patients who are candidates for surgical valve replacement (AVR) may benefit from diminished length of cardiopulmonary bypass time. Sutureless valve technology for AVR may facilitate the performance of the operation through smaller incisions, and more expeditiously due to the ability to anchor traditional bovine pericardial prostheses without the need for sutures. We report the first successful US implants of the Sorin PERCEVAL valve as part of the FDA IDE trial.